News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,619 Results
Type
Article (14282)
Company Profile (281)
Press Release (254056)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79604)
Career Advice (154)
Deals (13246)
Drug Delivery (35)
Drug Development (50480)
Employer Resources (32)
FDA (5734)
Job Trends (5154)
News (144560)
Policy (10037)
Tag
Academia (920)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21696)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5762)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4578)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1480)
Cardiovascular disease (117)
Career advice (134)
Career pathing (2)
CAR-T (117)
Cell therapy (331)
Cervical cancer (8)
Clinical research (41104)
Collaboration (542)
Compensation (258)
Complete response letters (13)
COVID-19 (1037)
CRISPR (42)
C-suite (164)
Cystic fibrosis (76)
Data (1524)
Denatured (11)
Depression (30)
Diabetes (139)
Diagnostics (1318)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29860)
Editorial (18)
Employer branding (4)
Employer resources (30)
Events (48665)
Executive appointments (464)
FDA (6433)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (366)
Government (1081)
Grass and pollen (2)
Guidances (22)
Healthcare (6604)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1102)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7279)
IRA (11)
Job creations (863)
Job search strategy (128)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (101)
Machine learning (3)
Management (8)
Manufacturing (140)
MASH (53)
Medical device (2606)
Medtech (2607)
Mergers & acquisitions (6298)
Metabolic disorders (390)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1257)
NextGen: Class of 2025 (2022)
Non-profit (857)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (35)
People (25673)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14518)
Phase II (19113)
Phase III (12093)
Pipeline (808)
Policy (46)
Postmarket research (852)
Preclinical (6141)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1423)
Recruiting (12)
Regulatory (8645)
Reports (15)
Research institute (940)
Resumes & cover letters (18)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1976)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (214)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (97)
Last 7 days (521)
Last 30 days (1521)
Last 365 days (19567)
2025 (6295)
2024 (20564)
2023 (22429)
2022 (26875)
2021 (27876)
2020 (23434)
2019 (16257)
2018 (11762)
2017 (13759)
2016 (11851)
2015 (14406)
2014 (10426)
2013 (7508)
2012 (7538)
2011 (7634)
2010 (7433)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17330)
Australia (2935)
California (3865)
Canada (1141)
China (360)
Colorado (150)
Connecticut (152)
Delaware (102)
Europe (37336)
Florida (466)
Georgia (116)
Idaho (16)
Illinois (232)
India (10)
Indiana (91)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (473)
Massachusetts (3085)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (968)
New Mexico (12)
New York (1045)
North Carolina (555)
North Dakota (5)
Northern California (1703)
Ohio (113)
Oklahoma (9)
Oregon (21)
Pennsylvania (741)
Puerto Rico (6)
Rhode Island (19)
South America (209)
South Carolina (4)
Southern California (1489)
Tennessee (25)
Texas (450)
United States (13282)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (352)
Wisconsin (15)
268,619 Results for "stoke therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Biogen and Stoke Strike Dravet Syndrome Co-Development Deal
The partnership splits the rights to Stoke’s epilepsy antisense oligonucleotide, with up to $385 million in potential payments due to Stoke.
February 18, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Stoke Therapeutics Announces CEO Transition
March 18, 2025
·
9 min read
Press Releases
Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
1 min read
Press Releases
Stoke Therapeutics to Present at Upcoming Investor Conferences in March
February 26, 2025
·
1 min read
Press Releases
Stoke Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 18, 2025
·
11 min read
Genetown
Stoke Therapeutics to Present at Upcoming Investor Conferences in June
Stoke Therapeutics, Inc. today announced that management will present at the following upcoming investor conferences.
June 3, 2024
·
1 min read
Press Releases
Stoke Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Business
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
Stoke Therapeutics, Inc. today announced the appointment of Thomas (Tommy) Leggett as Chief Financial Officer.
April 29, 2024
·
5 min read
Business
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
Stoke Therapeutics, Inc. today announced the appointment of Jason Hoitt as Chief Commercial Officer.
April 17, 2024
·
6 min read
Press Releases
Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
February 19, 2025
·
16 min read
1 of 26,862
Next
